Insiders / Coughlin Timothy
Coughlin Timothy
CIK 1376043personinsider
Companies
4
First seen
May 13, 2026
Last activity
Jun 16, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| ADC Therapeutics SA · ADCT | 72,400 | — |
| Travere Therapeutics, Inc. · TVTX | 56,250 | — |
| Vir Biotechnology, Inc. · VIR | 16,000 | — |
| Atyr Pharma Inc · ATYR | — | — |
All securities held
6 positions · latest reported per filing
| Company | Security | Shares |
|---|---|---|
| ADC Therapeutics SA | Common Shares | 72,400 |
| Atyr Pharma Inc | Stock Option (right to buy)Derivative | 50,000 |
| Travere Therapeutics, Inc. | Common Stock | 56,250 |
| Travere Therapeutics, Inc. | Stock option (right to buy)Derivative | 12,000 |
| Vir Biotechnology, Inc. | Common Stock | 16,000 |
| Vir Biotechnology, Inc. | Stock Option (Right to Buy)Derivative | 16,000 |
Activity
InsidersInstitutions
This person's insider trades (Form 4), across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | Sell | TVTX Travere Therapeutics, Inc. Common Stock | $500.7K | -10K -15.09% | 56,250 0.06% of shares | medium |
| Jun 12, 2026 | Exercise | TVTX Travere Therapeutics, Inc. Common Stock | $265.2K | +10K +17.78% | 66,250 0.07% of shares | low |
| May 15, 2026 | Sell | TVTX Travere Therapeutics, Inc. Common Stock | $141.3K | -3K -5.86% | 52,250 0.06% of shares | medium |
| Jun 3, 2026 | Other | ADCT ADC Therapeutics SA Common Shares | $38.8K | -13K -14.82% | 72,400 0.06% of shares | low |
| Jun 9, 2026 | Grant | VIR Vir Biotechnology, Inc. Common Stock | $0 | +8K +100.00% | 16,000 <0.01% of shares | low |
| Jun 9, 2026 | Grant | VIR Vir Biotechnology, Inc. Common Stock | $0 | +8K | 8,000 <0.01% of shares | low |
| Jun 1, 2026 | Grant | ADCT ADC Therapeutics SA Common Shares | $0 | +45K +112.50% | 85,000 0.07% of shares | low |
| May 19, 2026 | Grant | TVTX Travere Therapeutics, Inc. Common Stock | $0 | +4K +7.66% | 56,250 0.06% of shares | low |
| Jun 12, 2026 | Exercise | TVTX Travere Therapeutics, Inc. Stock Option (Right to Buy) | — | -10K -100.00% | 0 0.00% of shares | low |
| Jun 9, 2026 | Grant | VIR Vir Biotechnology, Inc. Stock Option (Right to Buy) | — | +16K | 16,000 <0.01% of shares | low |